...
首页> 外文期刊>Brazilian Journal of Medical and Biological Research >c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors
【24h】

c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors

机译:C-ERBB-2犬乳腺肿瘤中的表达和核渗透

获取原文

摘要

The objective of the present investigation was to study the expression of c-erbB-2 and MIB-1 and try to associate them with morphological features of the cell such as nuclear pleomorphism, mitotic count and histological grade in a series of 70 canine mammary gland tumors, 22 of them benign and 48 malignant. Tumors were collected at the Veterinary Hospital of UFMG (Brazil) and the Veterinary Faculty of Porto University (Portugal). c-erbB-2 expression was determined according to the guidelines provided by the manufacturer of the HercepTest system and nuclear pleomorphism, mitotic count and histological grade according the Elston and Ellis grading system. The HercepTest is the FDA-approved in vitro diagnostic test marketed by Dako. It is a semi-quantitative immunohistochemical assay used to determine overexpression of HER2 protein (human epidermal growth factor receptor) in breast cancer tissue. MIB-1 expression was also evaluated in 28 malignant tumors. Seventeen (35.4%) of the malignant tumors were positive for c-erbB-2 expression, which was positively associated with nuclear pleomorphism (P
机译:本研究的目的是研究C-ERBB-2和MIB-1的表达,并尝试将它们与细胞的形态特征相关联,例如核粘合剂,有丝分裂计数和组织学等级中的一系列70甘氨酸乳腺肿瘤,其中22个良性和48恶性肿瘤。在UFMG(巴西)的兽医医院和波尔图大学兽医学院(葡萄牙)收集肿瘤。根据ELSTON和ELLIS分级系统,根据赫斯佩斯系统和核渗透,有丝分裂计数和组织学等级提供的指导方针确定C-ERBB-2表达。 Herceptest是达科销售的FDA批准的体外诊断测试。它是一种半定量免疫组织化学测定,用于确定乳腺癌组织中HER2蛋白(人表皮生长因子受体)的过表达。 MIB-1表达也在28个恶性肿瘤中进行评估。 17(35.4%)的恶性肿瘤对于C-ERBB-2表达阳性,其与核渗透阳性相关(P

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号